MICHAEL STAVERSKY: Open Payments
NPI 1093317646 · FRANKLIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,743 in 142 payments from 28 companies in 2025. Trend: 2023 $442 · 2024 $2,158 · 2025 $2,743
Food & beverage: $2,743
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $330 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $250 |
| SANOFI-AVENTIS U.S. LLC | 9 | $232 |
| AstraZeneca Pharmaceuticals LP | 8 | $200 |
| Novo Nordisk Inc | 9 | $174 |
| Amgen Inc. | 10 | $169 |
| Axsome Therapeutics, Inc. | 9 | $163 |
| PFIZER INC. | 8 | $160 |
| Vanda Pharmaceuticals Inc. | 5 | $148 |
| Insulet Corporation | 8 | $140 |
Products named: CAPLYTA, TZIELD, Auvelity, QULIPTA, Omnipod, VRAYLAR, FARXIGA, HETLIOZ.
Industry payments across TN — which companies pay providers there.
